News Focus
News Focus
Followers 178
Posts 16063
Boards Moderated 1
Alias Born 01/26/2016

Re: CaptainObvious post# 514653

Saturday, 09/17/2022 1:48:10 PM

Saturday, September 17, 2022 1:48:10 PM

Post# of 819205
CaptainObvious,

This correction seems to have been written up ahead of time and submitted only after public review in the US of the proposed changes and the rational for them. Again, NWBO had been asked about this long before but only submitted it after public viewing of the changes which is part of “the process” in FDA guidance. This “process” and failure of Right To Try legislation to provide a path and funding kept the artisan method from happening on a lottery style basis. Funding from the outside from foundations or other private donors in the US never materialized either. The issue is that vested interests really don’t want a cure or a logical pathway to it and there were even talks about this a while back from some folks pointing out the damage that would be done to the status quo because of a cure. That kind of thinking minimizes the impact on patients and prioritizes the focus squarely on the financial impact of the bottom line which is not unlike actuaries determining the impact in the cost of injury or lives vs bottom line change created by a recall of any given product. The big question that remains is into whose hands will investors, including Linda, entrust this breakthrough to. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News